Rezolute Competitors

Stocks . USA . 
Stock . Rezolute
RZLT Stock  USD 3.34  0.09  2.77%   
Rezolute competes with Tyra Biosciences, Savara, Geron, ProKidney Corp, and Kura Oncology; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Rezolute competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Rezolute to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Rezolute Correlation with its peers.
For more information on how to buy Rezolute Stock please use our How to Invest in Rezolute guide.

Rezolute vs Eyepoint Pharmaceuticals Correlation

Excellent diversification

The correlation between Rezolute and EYPT is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and EYPT in the same portfolio, assuming nothing else is changed.

Moving against Rezolute Stock

  0.68ARWR Arrowhead PharmaceuticalsPairCorr
  0.64MRKR Marker TherapeuticsPairCorr
  0.64BOLT Bolt BiotherapeuticsPairCorr
  0.6AEON AEON BiopharmaPairCorr
  0.59CRDF Cardiff Oncology Buyout TrendPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.173.3417.31
Details
Intrinsic
Valuation
LowRealHigh
0.163.2117.18
Details
Naive
Forecast
LowNextHigh
0.031.5115.48
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.782.773.76
Details

Rezolute Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Rezolute and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Rezolute and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Rezolute does not affect the price movement of the other competitor.

High positive correlations

EYPT
+ 0.85
SVRA
GERN
+ 0.81
TYRA
GERN
+ 0.76
SVRA
EYPT
+ 0.72
GERN
SVRA
+ 0.64
TYRA
EYPT
+ 0.63
TYRA
  

High negative correlations

DAWN
- 0.69
KURA
MRVI
- 0.62
PROK
KURA
- 0.61
TYRA
PROK
- 0.59
TYRA
KURA
- 0.48
GERN
PROK
- 0.47
SVRA

Risk-Adjusted Indicators

There is a big difference between Rezolute Stock performing well and Rezolute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rezolute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TYRA  2.85  1.27  0.47  1.91  1.76 
(3.45)
 6.05 
(3.43)
 34.11 
SVRA  3.16  0.48  0.15  0.60  3.03 
(4.15)
 8.25 
(4.98)
 24.50 
GERN  2.64  0.23  0.07  0.29  2.77 
(3.54)
 6.72 
(4.29)
 16.99 
PROK  3.82 (0.36) 0.00 (1.25) 0.00 
 0.00 
 6.82 
(8.95)
 22.38 
KURA  2.83 (0.23) 0.00 (0.85) 0.00 
 0.00 
 4.96 
(5.08)
 22.27 
MRVI  3.01  0.34  0.07 (0.61) 3.31 
(3.66)
 8.38 
(6.35)
 22.00 
PRME  4.52 (0.04)(0.01) 0.00  4.89 
(5.20)
 11.05 
(8.19)
 24.90 
DAWN  4.41  0.89  0.20 (19.96) 3.67 
(6.30)
 13.81 
(6.53)
 39.62 
NBTX  3.21  0.40  0.11  2.00  3.20 
(3.84)
 6.58 
(5.64)
 18.61 
EYPT  3.28  0.36  0.08  2.10  3.66 
(3.64)
 8.15 
(4.98)
 23.49 

Rezolute Competitive Analysis

The better you understand Rezolute competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Rezolute's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Rezolute's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RZLT TYRA SVRA GERN PROK KURA MRVI PRME DAWN NBTX
 2.77 
 3.34 
Rezolute
 4.70 
 30.82 
Tyra
 3.23 
 5.40 
Savara
 3.01 
 1.37 
Geron
 7.04 
 1.98 
ProKidney
 1.22 
 8.12 
Kura
 2.04 
 3.36 
Maravai
 8.19 
 3.81 
Prime
 5.26 
 11.16 
Day
 4.07 
 21.00 
Nanobiotix
Market Volatility
(90 Days Market Risk)
Extremely Dangerous
Not too volatile
Slightly risky
Dangerous
Dangerous
Somewhat reliable
Risky
Very risky
Slightly risky
Not too volatile
Market Performance
(90 Days Performance)
Soft
Solid
Fair
Mild
Weakest
Weakest
Mild
Weakest
Fair
Fair
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Fair
Low
Small
High
Low
Fair
Small
Moderate
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Buy
Strong Hold
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
61.78
50.83
39.23
4.85
0.74
25.73
7.22
6.7
31.45
1.71
Net Asset
175.49 M
363.56 M
212.88 M
593.78 M
441.07 M
760.16 M
1.01 B
297.51 M
582.79 M
67.42 M
Profit Margin
N/A
N/A
N/A
-0.44
N/A
-2.08
-0.63
N/A
-1.14
N/A
EBITDA
(79.86 M)
(103.66 M)
(102.27 M)
(154.85 M)
(158.49 M)
(169.5 M)
(156.92 M)
(196.34 M)
(86.32 M)
(58.32 M)
Current Valuation
150.62 M
1.39 B
1.04 B
615.93 M
34 M
184.21 M
621.8 M
653.97 M
760.83 M
1.07 B
Price To Book
2.05
6.14
12.02
3.52
97.15
2.95
1.99
4.63
2.68
65.02
Operating Margin
N/A
N/A
N/A
-0.29
-176.13
-3.86
-0.81
-44.06
-0.61
0.0306
Retained Earnings
(403.86 M)
(251.31 M)
(489.25 M)
(1.77 B)
(1.2 B)
(895.42 M)
140.89 M
(687.21 M)
(554.08 M)
(68.13 M)
Current Asset
N/A
N/A
N/A
115.89 M
N/A
86.87 M
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-0.31
N/A
N/A
Beta
0.4
1.07
0.28
0.59
1.82
0.25
0.33
2.72
-1.27
0.47
Number Of Employees
75
60
59
229
204
192
550
214
184
103
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
99.55
N/A
N/A
Shares Outstanding
92.73 M
53.37 M
203.47 M
638.36 M
141.55 M
87.02 M
145.02 M
180.51 M
102.68 M
48.39 M
Three Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.82
N/A
N/A
Cash Flow From Operations
(69.08 M)
(69.77 M)
(89.09 M)
(218.62 M)
(126.35 M)
134.32 M
7.46 M
(122.86 M)
(78.11 M)
(19.55 M)
Total Debt
1.61 M
6.22 M
26.73 M
121.72 M
3.24 M
16.59 M
376.69 M
40.79 M
2.6 M
50.9 M
Return On Equity
-0.59
-0.35
-0.79
-0.3
-0.42
-0.65
-0.41
-1.12
-0.3
-1.99
Return On Asset
-0.37
-0.23
-0.4
-0.0779
-0.26
-0.27
-0.0778
-0.36
-0.19
-0.42
Number Of Shares Shorted
18.89 M
5.07 M
22.32 M
70.45 M
15.25 M
12.31 M
12.28 M
26.3 M
11.38 M
28.84 K
Book Value Per Share
1.62
5.26
0.45
0.39
-7.41
2.79
1.7
0.92
4.39
-1.71
Current Liabilities
N/A
N/A
N/A
6.63 M
N/A
5.05 M
N/A
N/A
N/A
N/A
Total Asset
175.49 M
363.56 M
212.88 M
593.78 M
441.07 M
760.16 M
1.01 B
297.51 M
582.79 M
67.42 M
Debt To Equity
0.001
0.009
0.21
0.39
5.66
0.013
0.69
0.18
0.002
N/A
Short Ratio
2.3
8.86
7.99
9.04
12.42
7.53
10.24
6.85
4.21
0.8
Target Price
4.25
37.88
10.81
3.4
6.5
32.55
3.93
6.46
23.56
23.38
Shares Owned By Institutions
89.49
96.84
84.18
81.05
29.06
98.45
89.4
62.76
85.22
11.71
Market Capitalization
309.71 M
1.73 B
1.11 B
874.55 M
595.65 M
702.67 M
1.23 B
687.75 M
1.15 B
1.02 B
Price To Earning
N/A
-3.33
-2.46
-12.48
N/A
-9.03
7.79
14.4
3.88
N/A
Price To Earnings To Growth
N/A
0.28
N/A
-2.38
N/A
N/A
-0.22
N/A
N/A
N/A
Price To Sales
N/A
N/A
131146.0
4.77
800.61
6.75
6.4
115.07
8.57
100.02
Net Income
(74.41 M)
(86.48 M)
(95.88 M)
(174.57 M)
(163.34 M)
(173.98 M)
(259.62 M)
(195.88 M)
(95.5 M)
(68.13 M)
Earnings Per Share
-0.97
-1.88
-0.53
-0.12
-0.51
-2.48
-0.84
-1.31
-1.52
-1.3
Shares Owned By Insiders
10.51
3.16
2.26
0.09
25.38
2.14
12.01
17.62
16.93
N/A
Revenue
N/A
N/A
N/A
76.99 M
76 K
53.88 M
259.19 M
2.98 M
131.16 M
(11.61 M)
Working Capital
159.23 M
332.87 M
187.41 M
402.69 M
359.67 M
666.12 M
372.18 M
173.93 M
488.88 M
2.53 M
Cash And Equivalents
150.41 M
275.11 M
142.62 M
219.29 M
21.88 M
450.26 M
617.45 M
146.66 M
394.86 M
63.02 M
Cash Per Share
3.87
6.61
1.25
0.58
0.36
6.73
4.69
6.39
5.38
1.81
Gross Profit
N/A
N/A
(83.8 M)
97.86 M
744 K
(120.28 M)
40.54 M
(154.05 M)
119.56 M
10.16 M
Day Typical Price
3.29
31.01
5.46
1.37
2.04
8.16
3.38
3.93
11.24
21.15
Accumulation Distribution
0.068
0.0644
0.0514
0.05
0.1
0.0313
0.049
0.11
0.0442
0.0612
Market Facilitation Index
0.23
2.07
0.29
0.07
0.22
0.26
0.17
0.45
0.51
1.34
Daily Balance Of Power
0.3913
(0.73)
(0.62)
0.5714
(0.68)
(0.38)
(0.41)
(0.76)
(1.22)
(0.66)
Period Momentum Indicator
0.09
(1.52)
(0.18)
0.04
(0.15)
(0.10)
(0.07)
(0.34)
(0.62)
(0.89)
Rate Of Daily Change
1.03
0.95
0.97
1.03
0.93
0.99
0.98
0.92
0.95
0.96
Day Median Price
3.26
31.11
5.49
1.37
2.07
8.18
3.39
3.99
11.27
21.22
Price Action Indicator
0.12
(1.05)
(0.18)
0.025
(0.17)
(0.11)
(0.06)
(0.34)
(0.42)
(0.67)
Relative Strength Index
43.81
67.08
47.76
54.17
40.1
39.81
47.52
47.13
N/A
49.73
Coefficient Of Variation
2455.96
360.23
825.09
1269.65
(1,444)
(1,814)
1256.16
57513.99
764.49
943.87
Mean Deviation
7.32
2.85
3.16
2.64
3.82
2.83
3.01
4.52
4.41
3.21
Jensen Alpha
0.5768
1.27
0.4805
0.2304
(0.36)
(0.23)
0.3434
(0.04)
0.8917
0.4023
Total Risk Alpha
(0.12)
1.06
0.3029
0.0953
(0.59)
(0.40)
0.1215
(0.28)
0.5577
0.2181
Sortino Ratio
0.0314
0.475
0.1504
0.0685
N/A
N/A
0.0748
(0.01)
0.2028
0.1075
Downside Variance
278.33
6.98
9.98
11.03
N/A
N/A
15.02
24.69
17.78
12.13
Standard Deviation
13.97
4.68
4.29
3.46
4.97
3.79
4.2
5.81
6.88
3.96
Kurtosis
25.69
13.51
2.96
0.4215
0.5031
2.71
1.27
0.3533
5.16
(0.07)
Potential Upside
18.05
6.05
8.25
6.72
6.82
4.96
8.38
11.05
13.81
6.58
Treynor Ratio
(1.10)
1.91
0.6001
0.2874
(1.25)
(0.85)
(0.61)
1.0E-4
(19.96)
2.0
Maximum Drawdown
99.29
34.11
24.5
16.99
22.38
22.27
22.0
24.9
39.62
18.61
Variance
195.28
21.91
18.43
11.95
24.67
14.33
17.67
33.71
47.35
15.67
Market Risk Adjusted Performance
(1.09)
1.92
0.6101
0.2974
(1.24)
(0.84)
(0.60)
0.0101
(19.95)
2.01
Risk Adjusted Performance
0.0389
0.2092
0.096
0.0649
(0.04)
(0.03)
0.0659
0.01
0.1036
0.0848
Skewness
(3.85)
2.88
1.13
0.2593
(0.62)
0.7892
0.5075
0.7367
1.84
0.3866
Semi Deviation
15.89
1.76
3.03
2.77
N/A
N/A
3.31
4.89
3.67
3.2
Information Ratio
0.0375
0.268
0.1107
0.0658
(0.08)
(0.07)
0.0689
(0.01)
0.1243
0.0946
Value At Risk
(9.22)
(3.43)
(4.98)
(4.29)
(8.95)
(5.08)
(6.35)
(8.19)
(6.53)
(5.64)
Expected Short fall
(8.39)
(3.45)
(4.15)
(3.54)
N/A
N/A
(3.66)
(5.20)
(6.30)
(3.84)
Downside Deviation
16.68
2.64
3.16
3.32
N/A
N/A
3.88
4.97
4.22
3.48
Semi Variance
252.44
3.1
9.15
7.69
N/A
N/A
10.93
23.96
13.43
10.23

Rezolute Competition Performance Charts

Five steps to successful analysis of Rezolute Competition

Rezolute's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Rezolute in relation to its competition. Rezolute's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Rezolute in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Rezolute's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Rezolute, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Rezolute position

In addition to having Rezolute in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Rezolute Stock Analysis

When running Rezolute's price analysis, check to measure Rezolute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rezolute is operating at the current time. Most of Rezolute's value examination focuses on studying past and present price action to predict the probability of Rezolute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rezolute's price. Additionally, you may evaluate how the addition of Rezolute to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY